WASHINGTON – U.S. Senator Chris Coons (D-Del.) released the following statement today after the Supreme Court issued its unanimous opinion in U.S. Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine, concluding that the anti-choice plaintiffs did not have legal standing to challenge the FDA’s changes to its regulations of mifepristone, a drug most commonly used to end an early pregnancy:
“This decision is a victory for those who believe that every woman in America has the right to make her own reproductive health care choices. I’m glad this decision allows mifepristone to remain on the market and maintains access to this critical medication. The court’s opinion also reaffirms the independence of the FDA, which approved mifepristone as safe and effective after a thorough and comprehensive review process more than two decades ago.
“While I welcome this news, the court’s decision to strike down Roe v. Wade two years ago paved the way for increasing attacks on reproductive freedom, including access to contraception and fertility treatments. I remain committed to strengthening access to women’s health care and will fight any attempts to further erode reproductive freedom.”
Senator Coons is a member of the Senate Judiciary Committee.